Historical record - last NADAC publication: 10/23/2019
Product Information
TIKOSYN 250 MCG CAPSULE is a brand product labeled by Pfizer Inc., priced at $9.9057 per EA under NDC 00069581061. Its NADAC has been published 220 times since Aug 3, 2016.
The High Outlier badge above means this manufacturer's average price in the dofetilide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.25 mg/1
Manufacturer
Pfizer Inc.NDC
00069581061
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
10/23/2019
Active Ingredients
DOFETILIDEApproval Type
New Drug (NDA)
FDA Application
NDA020931On Market Since
10/1/1999
Pharmacological Classes
Price Statistics
The NADAC for TIKOSYN 250 MCG CAPSULE has been published 220 times since Aug 3, 2016, and over the history we have for it it has risen 29.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.9057 per EA |
|---|---|
| All-time high | $10.1228 (May 16, 2018) |
| All-time low | $7.6640 (Aug 3, 2016) |
| Median price | $9.9057 |
| Average price | $9.4836 |
| Largest weekly change | +9.4% (Jan 4, 2017) |
| Weeks tracked | 220 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIKOSYN 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIKOSYN 250 MCG CAPSULE, manufactured by Pfizer Inc., is $9.9057 per EA (NDC 00069581061), effective Oct 14, 2020.
How has the price of TIKOSYN 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIKOSYN 250 MCG CAPSULE has risen 29.3%. It has been tracked across 220 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for TIKOSYN 250 MCG CAPSULE?
Since Aug 3, 2016, the NADAC for TIKOSYN 250 MCG CAPSULE has ranged from a low of $7.6640 (Aug 3, 2016) to a high of $10.1228 (May 16, 2018), with a median of $9.9057 per EA.
Are there cheaper alternatives to TIKOSYN 250 MCG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TIKOSYN 250 MCG CAPSULE, but none are currently priced below it.
Who manufactures TIKOSYN 250 MCG CAPSULE?
TIKOSYN 250 MCG CAPSULE (NDC 00069581061) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification